Printer Friendly

PAUL J. SEKHRI JOINS PERSEPTIVE BIOSYSTEMS AS MARKETING DIRECTOR, ANALYTICAL PRODUCTS

 CAMBRIDGE, Mass., May 5 /PRNewswire/ -- Paul J. Sekhri has joined PerSeptive Biosystems, Inc. (NASDAQ: PBIO) as marketing director, Analytical Products, the company announced today. Sekhri comes to PerSeptive Biosystems from Millipore Corporation where he had been senior manager, Biotechnology Market Development.
 Sekhri will be responsible for PerSeptive's ImmunoDetection(tm) products that combine the flow-through characteristics of the company's Perfusion Chromatography(R) process with the protein specific high sensitivity of immunoassays. This growing portfolio includes ID(tm) Sensor Cartridges; Real-Time Process Monitor(tm) (RPM(tm)), the first instrument to perform real-time immunoassays to monitor biopharmaceutical production processes such as purification and fermentation; and an ImmunoDetection(tm) workstation for the research market to be introduced later this year.
 "Paul Sekhri adds another level of experienced biopharmaceutical marketing capabilities to our marketing team," said Robert B. Anacone, senior vice president, Marketing and Sales, of PerSeptive Biosystems. "We expect that his background will help establish our innovative ImmunoDetection products as important new solutions for the biopharmaceutical industry."
 Sekhri was responsible for the successful product development and launch of Millipore's Viresolve(tm) viral membrane filters. He also served as European liaison of the company's biotechnology marketing efforts. Prior to Millipore, Sekhri was director of Marketing at Zymark Corporation, and earlier served as marketing manager at Genex Corporation. He began his career as a financial consultant/account executive at Dean Witter Reynolds.
 Sekhri received a B.S. degree in zoology from the University of Maryland, and a M.S. degree in anatomy from the University of Maryland School of Medicine. Sekhri was an assistant professor at Towson State University, where he taught undergraduate anatomy and physiology.
 PerSeptive Biosystems designs, manufactures and markets proprietary products and systems for the purification and analysis of biomolecules. These bioseparations products are designed to reduce significantly the time and cost required for the development and manufacture of biopharmaceuticals. The company's current and planned products for the purification and analysis of biomolecules are based on three interrelated core technologies: Perfusion Chromatography(R) for high resolution separations of biomolecules 10 to 1,000 times faster than conventional chromatography, ImmunoDetection(tm) for real-time immunoassays in a flow-through cartridge format and Rational Surface Design(tm) synthetic surfaces that bind biomolecules with the high specificity of antibodies.
 -0- 5/5/93
 /CONTACT: Robert B. Anacone, senior vp-marketing and sales of PerSeptive Biosystems, Inc., 617-621-1787/
 (PBIO)


CO: PerSeptive Biosystems, Inc. ST: Massachusetts IN: MTC SU: PER

MP -- NE002 -- 4718 05/05/93 09:00 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:May 5, 1993
Words:408
Previous Article:UNITED HEALTHCARE REPORTS FIRST QUARTER RESULTS: REVENUE, EPS UP 42 PERCENT IN 18TH CONSECUTIVE RECORD QUARTER
Next Article:READER'S DIGEST TO PUBLISH NEW EDITION IN CZECH REPUBLIC
Topics:


Related Articles
ROBERT A. FEIN PROMOTED TO SENIOR VICE PRESIDENT, FINANCE FOR PERSEPTIVE BIOSYSTEMS
PERSEPTIVE BIOSYSTEMS, INC. ANNOUNCES SECOND QUARTER RESULTS
PERSEPTIVE BIOSYSTEMS ANNOUNCES ELECTION OF DR. WILLIAM POUNDS TO ITS BOARD OF DIRECTORS
PERSEPTIVE BIOSYSTEMS, INC. ANNOUNCES THE INTRODUCTION OF TWO NEW PERFUSION CHROMATOGRAPHY INSTRUMENTS
PERSEPTIVE BIOSYSTEMS ANNOUNCES AWARD OF PATENT FOR PERFUSIVE CHROMATOGRAPHY PARTICLES
PERSEPTIVE BIOSYSTEMS SUES PHARMACIA AND SEPRACOR FOR PATENT INFRINGEMENT
REGNIER, PH.D NAMED CHIEF TECHNICAL OFFICER OF PERSEPTIVE BIOSYSTEMS; CO-INVENTOR OF PERFUSION CHROMATOGRAPHY WILL LEAD TECHNOLOGY EFFORTS
PERSEPTIVE BIOSYSTEMS AGREES TO ACQUIRE PERSEPTIVE TECHNOLOGIES II CORPORATION
PERSEPTIVE BIOSYSTEMS REPORTS RESULTS FOR SECOND FISCAL QUARTER OF 1996
Perseptive Biosystems Realizes $12.9 Million From Selling Portion of Stock in Millennium Pharmaceuticals

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters